Trian nominates Peltz and former Disney exec to media giant's board

Trian nominates Peltz and former Disney exec to media giant's board


Nelson Peltz, founder and chief executive officer of Trian Fund Management, during the Future Investment Initiative (FII) Institute Priority Summit in Miami, Florida, on Thursday, March 30, 2023.

Marco Bello | Bloomberg | Getty Images

Trian Fund Management on Thursday announced it was nominating its CEO, Nelson Peltz, and former Walt Disney CFO Jay Rasulo to the media giant’s board, as the firm wages a contentious proxy fight with Disney.

“Unfortunately, the Board and CEO appear to have no conviction that things will get better,” the activist-investor firm said in a press release.

Trian had initially sought to nominate three or four board members, but after Rasulo accepted the invitation to be nominated, Trian decided the two would be a stronger option, according to a person familiar with the matter.

Disney fired back at the move by Trian by defending its current board.

“Disney has an experienced, diverse, and highly qualified Board that is focused on the long-term performance of the Company, strategic growth initiatives including the ongoing transformation of its businesses, the succession planning process, and increasing shareholder value,” Disney said in a statement Thursday.

Still, Disney said its governance and nominating committee will review the nominations and provide a recommendation to the board.

The announcement comes after Trian reignited its proxy battle with Disney last month. The firm announced it was seeking two board seats for Peltz and another media executive, following what it called “significant value destruction and missteps” that the board oversaw.

Disney shares are up more than 8% for the year, but they’ve far underperformed the S&P 500’s gains. The stock was up more than 2% Thursday.

Trian’s proxy fight comes as Disney CEO Bob Iger tries to right the ship after a broad restructuring that resulted in thousands of layoffs. The media giant, long known to be a box office monster, has suffered a number of disappointments in recent years. In an effort to re-strategize, Iger will cut back on movies and other new content to better the company’s financial standing, as it looks to cut billions of dollars in costs and make its streaming business profitable.

Disney has said the proxy fight is apparently in part due to a personal grudge held by Peltz’s ally and former Marvel boss Ike Perlmutter. Trian has oversight of shares owned by Perlmutter, who has been an outspoken critic of Disney CEO Bob Iger.

The fight launched by Trian last month came the morning after Disney appointed Morgan Stanley CEO James Gorman and former Sky TV boss Jeremy Darroch to its board, in what appeared to be a move to temper Trian’s discontent.



Source

Business class+? Delta says segmentation is coming to high-end cabins
Business

Business class+? Delta says segmentation is coming to high-end cabins

Nurphoto | Nurphoto | Getty Images Delta Air Lines is studying new types of airplane tickets — this time in the premium cabins at the front of the plane. Airlines spent years slicing up their coach cabins, from extra legroom seats to bare-bones basic economy fares that don’t allow changes or include a seat assignment. […]

Read More
Trump’s tariffs on Brazil could make your coffee even more expensive
Business

Trump’s tariffs on Brazil could make your coffee even more expensive

President Donald Trump’s proposed 50% tariff on Brazilian imports is bad news for coffee drinkers. Brazil, the largest U.S. supplier of green coffee beans, accounts for about a third of the country’s total supply, according to data from the U.S. Department of Agriculture. Coffee beans need to grow in a warm, tropical climate, making Hawaii […]

Read More
Space startup Varda raises 7 million in funding to make drugs in orbit
Business

Space startup Varda raises $187 million in funding to make drugs in orbit

Pavlo Gonchar | Lightrocket | Getty Images Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space. The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. […]

Read More